Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)

Phase 4 Completed 683 enrolled Johnson & Johnson Consumer and Personal Products Worldwide Pfizer · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this clinical trial was to assess the efficacy and safety of cetirizine HCl syrup vs. loratadine syrup vs. placebo syrup in the treatment of SAR in children 6 to 11 years old.

Timeline

Start: 2001-03
Primary completion: 2001-07
Completion: 2001-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cetirizine	Other / unclassified	10 mg	—
Comparator	Loratadine	Small molecule	10 mg	—

Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)

Summary

Timeline

Drugs

Indications